Related Experiment Video
Updated: Apr 24, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
Expression of ABCB6 is related to resistance to 5-FU, SN-38 and vincristine
Kentaro Minami1, Youhei Kamijo2, Yukihiko Nishizawa1
1Department of Molecular Oncology, Kagoshima University, Kagoshima, Japan Department of Clinical Pharmacy and Pharmacology, Kagoshima University, Kagoshima, Japan.
Abstract:
A previously established arsenite-resistant cell line, KAS, is also resistant to a variety of anticancer drugs. In order to understand responsible molecules for the multidrug resistance phenotype of KAS cells, we examined the expressions of ATP-binding cassette (ABC) transporters and found that the ABCB6 and ABCC1/ multidrug resistance protein 1 (ABCC1/MRP1) were increased. ABCC1/MRP1 was not completely responsible for the drug resistance spectrum of KAS cells and several reports have suggested that ABCB6 is related to anticancer drug and metal resistance. We, therefore, established and examined ABCB6-expressing KB cells and ABCB6-knockdown KAS cells. ABCB6 expression enhanced resistance to 5-fluorouracil (5-FU), SN-38 and vincristine (Vcr) but not to arsenite. Conversely, down-regulation of ABCB6 in KAS cells increased the sensitivity of KAS cells to 5-FU, SN-38 and Vcr, but not to arsenite. Our findings suggest that ABCB6 is involved in 5-FU, SN-38 and Vcr resistance.
Insights
The ATP-binding cassette (ABC) transporter ABCB6 contributes to multidrug resistance in cancer cells. This study shows ABCB6 enhances resistance to specific anticancer drugs like 5-fluorouracil, SN-38, and vincristine.
Area of Science:
- Molecular Biology
- Cancer Research
- Drug Resistance Mechanisms
Background:
- The KAS cell line exhibits resistance to both arsenite and multiple anticancer drugs.
- Understanding the molecular basis of this multidrug resistance is crucial for developing effective cancer therapies.
- ATP-binding cassette (ABC) transporters are frequently implicated in drug resistance phenotypes.
Purpose of the Study:
- To identify the specific ABC transporters responsible for the multidrug resistance in KAS cells.
- To elucidate the role of ABCB6 in the drug resistance profile of KAS cells.
- To investigate the functional significance of ABCB6 in mediating resistance to various anticancer agents.
Main Methods:
- Expression analysis of ABC transporters in KAS cells, focusing on ABCB6 and ABCC1/MRP1.
- Generation of KB cells overexpressing ABCB6.
- Generation of KAS cells with downregulated ABCB6 expression (knockdown).
- Assessment of cellular sensitivity to arsenite, 5-fluorouracil (5-FU), SN-38, and vincristine (Vcr) in engineered cell lines.
Main Results:
- Increased expression of ABCB6 and ABCC1/MRP1 was observed in KAS cells.
- ABCB6 overexpression in KB cells conferred resistance to 5-FU, SN-38, and Vcr, but not to arsenite.
- Downregulation of ABCB6 in KAS cells led to increased sensitivity to 5-FU, SN-38, and Vcr, without affecting arsenite sensitivity.
Conclusions:
- ABCB6 plays a significant role in mediating resistance to 5-fluorouracil, SN-38, and vincristine.
- ABCB6 is a key determinant of the multidrug resistance phenotype observed in KAS cells for these specific agents.
- Targeting ABCB6 may represent a potential strategy to overcome resistance to these anticancer drugs.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
ABC Transporters: Exporter
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:

